title: [Clinical study on post-operational anti-metastasis effect of xiaoliu pingyi mixture].
abstract: OBJECTIVE
  To observe the effect of combined use of chemotherapy (CT) and Xiaoliu Pingyi Mixture (XLPYM) in anti-metastasis, anti-relapse and tumor inhibition in patients after surgical operation.
  
  
  METHODS
  Nienty-six patients of common tumor after operation were divided into 2 groups, the 58 patients in the observed group treated with CT plus XLPYM and the 38 patients in the control group treated with CT alone. After 2 courses of treatment, the status of 1 year remote metastasis and in local relapse of tumor were observed. For patients of relapse or metastasis, another 2 courses of treatment was given, then the changes of tumor size, quality of life, body weight, peripheral blood cells, immunity and hemorrheology were estimated and compared between the two groups.
  
  
  RESULTS
  The remote metastatic rate and local relapse rate in the observed group were lower than those in the control group significantly (8.62% vs 44.74% and 15.52% vs 60.53%, P < 0.01). For patients of metastasis or relapse, the effective rate in the observed group was 46.24% and that in the control group was 24.00%, showing significant difference between the two groups (P < 0.05). Clinical observation also displayed that XLPYM could elevate the quality of life, regulate the disordered T-lymphocyte subsets, improve the hemorrheologic character and reduce the toxic-adverse reaction of CT in patients.
  
  
  CONCLUSIONS
  XLPYM in combining with CT has effects of tumor inhibition, anti-metastasis and anti-relapse in treating patients of common tumor in post-operational period.
authors.affiliation: Affiliated Hospital of Shandong University of TCM, Jinan 250011.
authors.forename: X R
authors.initials: XR
authors.lastname: Li
authors.forename: Y F
authors.initials: YF
authors.lastname: Zhou
authors.forename: Z H
authors.initials: ZH
authors.lastname: Jiao
mesh_terms: D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D008517:Phytotherapy; D011184:Postoperative Period; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery
chemical_list: D004365:Drugs, Chinese Herbal